Outpatient Surgeries Still Grew After COVID, Reshaping Care
A New Study Confirms the Outpatient Surge and Suggests That Many Patients Will Be Left Behind
In Their Own Words
FDA: Base Blood Donation Policy on Science, not Stigma
A Doctor’s Request for Change
Print:
The following excerpt is from an op-ed that first appeared in STATNews on February 5, 2023.
As a doctor, I have dedicated my life to saving the lives of others. But as a gay doctor, I have long been unable to do one simple thing that saves lives: donate blood.
For more than 30 years, policies in the United States have banned gay and bisexual men from donating blood. That could change — ending decades of discrimination — if the Food and Drug Administration’s newly announced proposal for blood donation is made permanent.
In 1985, the FDA placed a lifetime ban on gay and bisexual men donating blood in the U.S. That policy, based on fear and misconceptions of HIV and AIDS at the time, remained in place until December 2015, when the FDA revised the ban and replaced it with a one-year deferral period: Gay and bisexual men were allowed to donate blood if they had not engaged in any sexual activity with other men in the year prior to the donation. In April 2020, because of the Covid-19 pandemic and massive blood shortages, the FDA shortened the deferral period to three months. It is important to note that, under this policy, men who did not identify as having sexual contact with other men were not asked about sexual activity and did not have to undergo any waiting period before donating blood.
But even this three-month deferral stigmatized men who have sex with men by not imposing the same requirement for all blood donors. This policy reinforced negative stereotypes about gay and bisexual people, particularly that HIV is a “gay disease” when it affects people of all sexualities. It also supported the false perception that heterosexual people are at low risk for HIV infection.
Read the entire op-ed here.
| For more on this topic, see Kevin B. Johnson’s Philadelphia Inquirer op-ed |
Author
Scott Jelinek, MD, MPH
Fellow, Adolescent Medicine, Children’s Hospital of Philadelphia
More from LDI
Health Care Affordability
Expert Insights
LDI Fellows’ AI Program Could Save Medicare Billions in Overpayments
Replacing Flawed Current Payment Methods With the Machine Learning Model “Franklin,” Might Thwart Upcoding and Favorable Enrollee Selection by Medicare Advantage Firms
AI Prescribing Medications In Utah: A Flawed Regulatory Playbook
A First-of-Its-Kind Pilot Raises Safety Risks and Questions About Who Should Regulate Machines Acting Like Doctors
What The Pitt Gets Right About the U.S. Health Care System
LDI Fellows Weigh in on the HBO Max Show, Describing Real Challenges From High Patient Bills to Assaults on Nurses in the ER
U.S. Hospital Nurse Job Conditions Worsen After COVID, and Turnover Continues
Chart of the Day: National Study Shows Worse Nurse Job Satisfaction and Perceived Lower Care Quality as Staffing Shortages Persist Post-Pandemic